Promotional price valid on web orders only. Your contract pricing may differ. Interested in signing up for a dedicated account number?
Learn More
Learn More
OraSure Technologies OraQuick™ Advance™ Rapid HIV-1/2 Antibody Test
HIV Testing anytime, anywhere, made easy. The OraQuick™ ADVANCE™ Rapid HIV-1/2 Antibody Test is an easy-to-use rapid HIV test that offers several specimen types - oral fluid, fingerstick whole blood, venipuncture whole blood and plasma. Yielding accurate results in as little as 20 minutes.
Supplier: OraSure Technologies 10010079
missing translation for 'nonReturnableMessage'
missing translation for 'returnPolicyLabel'
Description
- The OraQuick™ ADVANCE™ Rapid HIV-1/2 Antibody Test detects antibodies to HIV-1 and HIV-2 in 20 minutes.
- Approved for oral fluid, plasma, fingerstick or venipuncture whole blood specimens.
- CLIA-waived for oral fluid, fingerstick and venipuncture whole blood and offers the ability to test in non-traditional testing environments, such as outreach programs and mobile testing clinics.
- CLIA Moderately Complex for plasma samples.
- The OraQuick™ ADVANCE™ is comprised of a single-use test device and a single-use vial containing a pre-measured amount of a buffered developer solution.
- Each component is sealed in separate compartments of a single pouch to form the test.
- 25 Test count packaging includes: (25) Divided Pouches with Test Device and 1 mL Vial Developer Solution, (5) Reusable Test Stands, (25) Specimen Collection Loops, (25) Information Pamphlets, Package Insert, Customer Letter.
- 100 Test count packaging includes: (100) Divided pouches with (1) test device, (1) absorbent pack, (1) 1 mL developer solution vial; (10) reusable test stands, (100) specimen collection loops, (100) subject information pamphlets, (1) package insert, (1) customer letter.
- Store unused tests at 2 to 27°C (36-80°F).
- If stored refrigerated, ensure that the divided pouch is brought to operating temperature (15-37°C, 59-99°F) before opening.
Specifications
ISO 13485 Certified. FDA approved under PMA BP010047. Inspected to 21 CFR 820 and MDSAP certification. | |
Detects HIV-1 and HIV-2. It is developed with synthetic peptides that represent the envelope region. | |
HIV-1/2 | |
25 Tests |
2°C to 27°C | |
Yes | |
Single-use |
Product Content Correction
Your input is important to us. Please complete this form to provide feedback related to the content on this product.
Product Title
Spot an opportunity for improvement?
Product Content Correction